SYRS insider transaction filings
Syros Pharmaceuticals, Inc. — 29 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2024-12-04. Screen SYRS transaction legs live →
Insider transaction summary — last 90 days
No Form 4 filings for SYRS between 2026-06-11 and 2026-09-09. The table below lists the most recent filings on record.
Recent Form 4 filings — Syros Pharmaceuticals, Inc.
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2024-12-04 | 4 | Simonian Nancy A — Director | Sale (S): 37,070 @ $0.27 | EDGAR |
| 2024-11-27 | 4 | Simonian Nancy A — Director | Sale (S): 134,713 @ $0.27 | EDGAR |
| 2024-11-20 | 4 | Stephens Kristin — Chief Development Officer | Sale (S): 36,133 @ $0.22 | EDGAR |
| 2024-11-20 | 4 | Roth David — Chief Medical Officer | Sale (S): 12,099 @ $0.20 | EDGAR |
| 2024-11-20 | 4 | Chee Conley — President & CEO, Director | Sale (S): 134,797 @ $0.20 | EDGAR |
| 2024-11-20 | 4 | Haas Jason — Chief Financial Officer | Sale (S): 137,803 @ $0.21 | EDGAR |
| 2024-11-20 | 4 | Quirk Gerald E — Chief Legal & Compliance Offic | Sale (S): 46,657 @ $0.22 | EDGAR |
| 2024-11-04 | 4 | Roth David — Chief Medical Officer | Option exercise (M): 18,875 · Tax withholding (F): 6,776 @ $2.09 · Option exercise (M): 18,875 (derivative) @ $0 | EDGAR |
| 2024-11-04 | 4 | Haas Jason — Chief Financial Officer | Option exercise (M): 18,875 · Tax withholding (F): 5,624 @ $2.09 · Option exercise (M): 18,875 (derivative) @ $0 | EDGAR |
| 2024-11-04 | 4 | Chee Conley — President & CEO, Director | Option exercise (M): 17,000 · Tax withholding (F): 8,707 @ $2.09 · Option exercise (M): 17,000 (derivative) @ $0 | EDGAR |
| 2024-11-04 | 4 | Stephens Kristin — Chief Development Officer | Option exercise (M): 17,000 · Tax withholding (F): 6,104 @ $2.09 · Option exercise (M): 17,000 (derivative) @ $0 | EDGAR |
| 2024-11-04 | 4 | Simonian Nancy A — Director | Option exercise (M): 40,125 · Option exercise (M): 40,125 (derivative) @ $0 | EDGAR |
| 2024-10-02 | 4 | Quirk Gerald E — Chief Legal & Compliance Offic | Option exercise (M): 10,000 · Tax withholding (F): 3,100 @ $2.10 · Option exercise (M): 10,000 (derivative) @ $0 | EDGAR |
| 2024-09-18 | 4 | Young Richard A — Director | Option exercise (M): 2,667 · Option exercise (M): 2,667 (derivative) @ $0 | EDGAR |
| 2024-09-18 | 4 | AKKARAJU SRINIVAS — Director | Option exercise (M): 2,667 · Option exercise (M): 2,667 (derivative) @ $0 | EDGAR |
| 2024-09-12 | 4 | Haas Jason — Chief Financial Officer | Purchase (P): 35,363 @ $1.55 · Purchase (P): 19,293 @ $1.58 · Purchase (P): 45,344 @ $1.68 | EDGAR |
| 2024-09-12 | 4 | Chee Conley — President & CEO, Director | Purchase (P): 50,000 @ $1.51 · Purchase (P): 50,000 @ $1.71 | EDGAR |
| 2024-07-02 | 4 | Young Richard A — Director | Sale (S): 34,837 @ $5.12 | EDGAR |
| 2024-06-07 | 4 | Eckhardt Sue Gail — Director | Grant/award (A): 4,000 @ $0 · Grant/award (A): 6,000 (derivative) @ $0 | EDGAR |
| 2024-06-07 | 4 | OH ANDREW M. — Director | Grant/award (A): 4,000 @ $0 · Grant/award (A): 6,000 (derivative) @ $0 | EDGAR |
| 2024-06-07 | 4 | Young Richard A — Director | Grant/award (A): 4,000 @ $0 · Grant/award (A): 6,000 (derivative) @ $0 | EDGAR |
| 2024-06-07 | 4 | Simonian Nancy A — Director | Grant/award (A): 4,000 @ $0 · Grant/award (A): 6,000 (derivative) @ $0 | EDGAR |
| 2024-06-07 | 4 | Dunsire Deborah — Director | Grant/award (A): 6,000 (derivative) @ $0 · Grant/award (A): 4,000 (derivative) @ $0 | EDGAR |
| 2024-06-07 | 4 | Fanucci Marsha — Director | Grant/award (A): 4,000 @ $0 · Grant/award (A): 6,000 (derivative) @ $0 | EDGAR |
| 2024-06-07 | 4 | AKKARAJU SRINIVAS — Director | Grant/award (A): 6,000 (derivative) @ $0 · Grant/award (A): 4,000 (derivative) @ $0 | EDGAR |
| 2024-06-07 | 4 | TYSON TIMOTHY — Director | Grant/award (A): 4,000 @ $0 · Grant/award (A): 6,000 (derivative) @ $0 | EDGAR |
| 2024-06-07 | 4 | WIRTH PETER — Director | Grant/award (A): 4,000 @ $0 · Grant/award (A): 6,000 (derivative) @ $0 | EDGAR |
| 2024-06-04 | 4 | Dunsire Deborah — Director | Option exercise (M): 4,000 · Option exercise (M): 4,000 (derivative) @ $0 | EDGAR |
| 2024-06-04 | 4 | AKKARAJU SRINIVAS — Director | Option exercise (M): 4,000 · Option exercise (M): 4,000 (derivative) @ $0 | EDGAR |
Recent 8-K events — Syros Pharmaceuticals, Inc.
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2025-03-04 | 8-K | 8.01 — Other Events | EDGAR |
| 2025-02-28 | 8-K | 3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-01-08 | 8-K | 3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing | EDGAR |
| 2024-12-06 | 8-K | 1.01 — Entry into a Material Definitive Agreement 9.01 — Financial Statements and Exhibits | EDGAR |
| 2024-11-18 | 8-K | 1.02 — Termination of a Material Definitive Agreement 2.04 — Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement ? 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | EDGAR |
| 2024-11-13 | 8-K | 2.04 — Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2024-09-05 | 8-K | 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2024-08-12 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2024-06-06 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 5.07 — Submission of Matters to a Vote of Security Holders 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=SYRS returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →